Medication adherence
Medication adherence is a clinical metric describing the extent to which a person’s medication-taking behavior corresponds with an agreed treatment regimen.
Medication adherence is a clinical metric describing the extent to which a person’s medication-taking behavior corresponds with an agreed treatment regimen. It can include whether treatment is initiated, how consistently doses are taken, and whether treatment is continued over time. Adherence is distinct from treatment efficacy: a medicine may be pharmacologically effective, but its real-world benefit can be reduced when doses are missed, treatment is modified without clinical guidance, or therapy is discontinued.
Medication adherence is particularly important in chronic conditions and long-term therapies, including type 2 diabetes, asthma, HIV/AIDS, schizophrenia, autoimmune disease, and cancer. It is influenced by treatment-related factors, patient beliefs and symptoms, self-care agency, patient education, social support, anxiety, access to care, and socioeconomic circumstances. In clinical and research settings, adherence may be assessed through patient reports, pharmacy or insurance claims, electronic monitoring, connected devices, or computational tools. Recent work spans socioeconomic factors in asthma self-care, SGLT2 inhibitor use in diabetes, and breast cancer therapy associated with pain and physical activity; the newer publications also extend this scope to oral chemotherapy, primary Sjögren disease, antiretroviral therapy, and care coordination.
- Adherence to Anticoagulants in People with Stroke and Atrial Fibrillation: Implementation of Standardised Analytic Methods in Australia and Canada. PMID 42717313
Where the papers sit
10 papers study medication adherence directly. Those 10 are one subject: Chronic Disease Treatment Adherence. Treatment adherence across chronic diseases is being measured with standardized methods and linked to beliefs, self-care, quality of life, and clinical control. Pharmacist-led mHealth, adaptive asthma support, exercise, and yoga are tested as adjuncts, without a single established intervention. No way of splitting those 10 scores better than chance. 1 new direction follows.
Medication adherence becomes a cross-jurisdiction measurement standard rather than only a patient behavior or treatment outcome
The post-stroke atrial-fibrillation DOAC study in Australia and Canada treats medication adherence as a problem of measurement infrastructure: instead of assuming that dispensing data yield directly comparable adherence estimates, it finds that differing analytic methods and data structures hinder reliable comparison and therefore implements harmonized variables and standardized TEN-SPIDERS-based methods across countries 42717313Sep. This shifts adherence into a role as a population-level evidence standard whose validity depends on interoperable methods, not merely on patients’ medication-taking behavior or on an intervention’s effect.
Recent Findings on medication adherence
Chronic Disease Treatment Adherence: Direct oral anticoagulants and antidiabetic therapies are being measured with standardized dispensing, claims, and Proportion of Days Covered methods to support real-world comparisons 42717313Sep42575546Aug. Patients’ medication beliefs and self-care capacity also shape adherence, with necessity-concern differentials and self-care agency associated with treatment-taking in primary Sjögren disease and oral chemotherapy 42631726Aug42663682Aug. Pharmacist-led mHealth produced large adherence gains and improved Health-Related Quality of Life, although its glycaemic effect varied by analysis and incomplete HbA1c data 42543085Aug. Adaptive asthma monitoring, care coordination, physical activity, yoga, and AI-based support are extending adherence research toward personalized interventions, with several studies still evaluating feasibility, acceptability, or planned randomized outcomes 42189631May42043924Apr42070391May42044105Apr42013303Apr. Standardized analytic methods, equity-sensitive education, and early follow-up therefore represent the clearest direction for improving measurement and sustained adherence across chronic diseases 42717313Sep42663682Aug42543085Aug.
Written from 10 PubMed abstracts, each one cited by PMID above. Published: 2026-08-30. Last written: 2026-09-11 by GPT. Drafted by language models from published abstracts; not medical advice.